FABP2 and HIV infectious disease: Several previous studies have investigated the association between HIV infection, loss of gut barrier integrity, and immune activation using plasma markers of innate immune activation (soluble CD14 [sCD14]) and of elevated gut epithelial turnover (intestinal fatty acid-binding protein [I-FABP]) (49–54).